Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
Critical Reviews™ in Eukaryotic Gene Expression
IF: 1.841 5-Year IF: 1.927 SJR: 0.627 SNIP: 0.516 CiteScore™: 1.96

ISSN Print: 1045-4403
ISSN Online: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukaryotGeneExpr.2016015964
pages 137-142

The Impacts of miRNAs in Glioblastoma Progression

Rasime Kalkan
Near East University, Faculty of Medicine, Department of Medical Genetics, Cyprus
Emine İkbal Atli
Department of Medical Genetics, Faculty of Medicine, Trakya University, Edirne, Turkey

ABSTRACT

miRNAs are short noncoding RNA sequences that cause translational repression or mRNA degradation. A growing number of studies have sought new biomarkers in GBM that will be important in disease progression and prognosis and as potential therapeutic targets. miRNA-profiling studies in glioblastoma patients have found that aberrant miRNA expression can be used as a target to develop new biomarkers for disease detection and for determining prognosis or therapeutic response. In evaluating the tumor or its therapeutic response, genetic abnormalities such as mutations, epigenetic abnormalities, and aberrant miRNA expressions can be useful markers. This review summarizes the known miRNAs according their therapeutic importance and their use as disease progression biomarkers.


Articles with similar content:

Hypoxia Is the Driving Force Behind GBM and Could Be a New Tool in GBM Treatment
Critical Reviews™ in Eukaryotic Gene Expression, Vol.25, 2015, issue 4
Rasime Kalkan
The Importance of Mutational Drivers in GBM
Critical Reviews™ in Eukaryotic Gene Expression, Vol.26, 2016, issue 1
Rasime Kalkan
Multiple-Scales Integrative Analysis of MicroRNAs Unveils Biomarkers and Key Regulatory Connections for Hepatocellular Carcinoma
Critical Reviews™ in Eukaryotic Gene Expression, Vol.29, 2019, issue 3
Xiaohong Xiang, Wanyan Deng, Keli Qian, Qian Li
Kruppel-Like Factor 4: From Physiological Functions to Tumor Therapy
Forum on Immunopathological Diseases and Therapeutics, Vol.7, 2016, issue 1-2
Peng Li, Ruocong Zhao, Yunxin Lai
Aberrant Regulation of Alternative Pre-mRNA Splicing in Hepatocellular Carcinoma
Critical Reviews™ in Eukaryotic Gene Expression, Vol.24, 2014, issue 2
Shuixiang Xie, Fan Zhu, Lijuan Liu, Chuanjie Zhang